Essential thrombocythemia is a chronic disease common in people over age 50 and slightly more common in women. Young people can develop it as well. It is characterised by the overproduction of platelets by megakaryocytes in the bone marrow. Essential thrombocythemia is an uncommon disorder where the body produces too many blood platelets. This condition may cause to feel fatigued, lightheaded and to experience headaches and vision changes. It also increases the risk of blood clots.
The greatest health risk in patients with ET is an increased risk of developing blood clots. Blood clots can be in the deep vessels of the legs or lungs; ET patients are also more likely to experience strokes and heart attacks. ET patients can develop clots elsewhere, including within the abdomen, an otherwise rare site for clots to form. The risk of clotting increases with age, and disease-associated risks may be quite different for children than for adults, with children generally being at low risk for clots and other problems related to ET.
In 2014, 295 cases of chikungunya were reported in EWNI of which 88% had acquired their infection in the Caribbean and South America.Diagnosis is generally made after a physical examination and a series of blood tests. Treatment varies from person to person. Smokers and people with a history of blood clots may need medications to reduce platelet count, while others with may only need to monitor their condition. The long-term outlook depends on your particular symptoms and risk factors. This condition is sometimes called essential thrombocythemia.